Tirzepatide therapy starts at 2.5 mg and escalates to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and sometimes 15 mg depending on response and tolerance
These agents, which have shown efficacy in non-transplant populations, present new opportunities for improving the management of diabetes mellitus in liver transplant recipients, potentially mitigating the adverse effects of PTDM and enhancing long-term outcomes
These examples showcase the promise of this new enzyme class
Another key action of semaglutide is its effect on appetite regulation
A provider who declines to prescribe split dosing is not being unhelpful
A healthcare professional, such as a Midi clinician, will review your medical history and discuss any concerns you may have before prescribing a GLP-1 medication